Wyss Zurich

Quality Assurance Manager
80-100 %

The Wyss Zurich is a joint accelerator of the ETH Zurich and the University of Zurich, which was made possible by a generous donation from the Swiss entrepreneur and philanthropist Dr. hc. mult. Hansjörg Wyss. The mission of Wyss Zurich is to drive the clinical translation and technology transfer of outstanding scientific discoveries into new therapies for patients and breakthrough innovations in the emerging fields of Regenerative Medicine and Robotics, and to promote hybrid technologies in these fields. Wyss Zurich brings together some of the world's leading experts to form multidisciplinary teams, pooling their knowledge and expertise.

The project MUVON is developing a low-risk, minimally invasive treatment that uses the patient's own muscle precursor cells (MPC) to regenerate the damaged sphincter muscle, thus potentially providing a cure for stress urinary incontinence, as the first target indication. Currently being at the end of Phase I clinical trial, the MUVON project has been supported by Wyss Zurich and will now proceed with the clinical and commercial development of their therapy, evaluating the efficacy of the approach during a Phase II clinical trial and undertaking all the required activities for regulatory approval. We are a young, dynamic, energetic team with outstanding dedication to bringing a significant change in patient's lives and have recently founded the UZH Spin-off MUVON Therapeutics which is linked to this project.

Your responsibilities

We are looking for an ambitious and flexible Quality Manager to strengthen our GMP team and support the production of an autologous cell product for use in phase II clinical trial in all quality relevant aspects according to the existing quality management system of Wyss Zurich.
Main Responsibilities:
Further tasks:

Your profile

Successfully finished studies in natural sciences (Bachelor/Master), preferably in the area of pharmacy, pharmaceutical technology, biology, biotechnology, or a comparable education

What we offer

We are a young, energetic team with outstanding dedication to bringing a significant change in patient's lives. Therefore, we have founded the UZH Spin-off MUVON Therapeutics in 2020, which is linked to this position and the phase II study. Our goal is to further strengthen the GMP team for the phase II productions at the Wyss Zurich, as well as drive the development of our revolutionary therapy and also provide an opportunity to extend employment through MUVON Therapeutics and participation in Startup success.

Place of work


Start of employment

The employment start date is 01.09.2021 or upon mutual agreement. Please submit your application by 15.08.2021

Further information